228 related articles for article (PubMed ID: 12358935)
21. STI-571 in chronic myelogenous leukaemia.
Tsao AS; Kantarijian H; Talpaz M
Br J Haematol; 2002 Oct; 119(1):15-24. PubMed ID: 12358949
[No Abstract] [Full Text] [Related]
22. Can grapefruit juice decrease the cost of imatinib for the treatment of chronic myelogenous leukemia?
Kimura S; Kako S; Wada H; Sakamoto K; Ashizawa M; Sato M; Terasako K; Kikuchi M; Nakasone H; Okuda S; Yamazaki R; Oshima K; Nishida J; Watanabe T; Kanda Y
Leuk Res; 2011 Jan; 35(1):e11-2. PubMed ID: 20952061
[No Abstract] [Full Text] [Related]
23. Concomitant myelodysplastic syndrome and chronic myeloid leukaemia: treatment outcomes with imatinib mesylate.
Mesa RA; Steensma DP; Hoyer J; Ketterling RP
Br J Haematol; 2003 Oct; 123(2):366-7. PubMed ID: 14531922
[No Abstract] [Full Text] [Related]
24. Generics in chronic myeloid leukemia: current arguments for and against and the established evidence.
Soysal T; Eskazan AE; Ar MC
Expert Rev Hematol; 2014 Dec; 7(6):697-9. PubMed ID: 25292262
[TBL] [Abstract][Full Text] [Related]
25. Chronic myeloid leukaemia. STI 571 magnifies the therapeutic dilemma.
Mughal TI; Goldman JM
Eur J Cancer; 2001 Mar; 37(5):561-8. PubMed ID: 11290430
[No Abstract] [Full Text] [Related]
26. Imatinib mesylate: a new pill for chronic myelogenous leukemia.
Parmar KK; King RS
Cancer Pract; 2001; 9(5):263-5. PubMed ID: 11879324
[No Abstract] [Full Text] [Related]
27. Decrease of resistance to imatinib in leukaemia.
Bakalova R; Zhelev Z; Ohba H
Lancet; 2002 May; 359(9319):1776-7. PubMed ID: 12049890
[No Abstract] [Full Text] [Related]
28. NICE widens patient group for leukaemia drug.
Kmietowicz Z;
BMJ; 2002 Oct; 325(7369):852. PubMed ID: 12386018
[No Abstract] [Full Text] [Related]
29. Glivec and beyond.
Eur J Cancer; 2006 Aug; 42(12):1695. PubMed ID: 16998957
[No Abstract] [Full Text] [Related]
30. Imatinib for chronic myeloid leukaemia: a NICE mess.
Lim D; Muir J
Lancet; 2001 Dec; 358(9296):1903. PubMed ID: 11741656
[No Abstract] [Full Text] [Related]
31. After imatinib: new hopes for chronic myeloid leukaemia.
Bradbury J
Drug Discov Today; 2005 Apr; 10(8):536-7. PubMed ID: 15837592
[No Abstract] [Full Text] [Related]
32. [Treatment of chronic myelogenous leukemia by using imatinib].
Jinnai I
Nihon Naika Gakkai Zasshi; 2005 Sep; 94(9):1819-24. PubMed ID: 16223141
[No Abstract] [Full Text] [Related]
33. Imatinib mesylate--gold standards and silver linings.
Peggs K
Clin Exp Med; 2004 Sep; 4(1):1-9. PubMed ID: 15598080
[TBL] [Abstract][Full Text] [Related]
34. Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate.
Arora B; Kumar L; Sharma A; Wadhwa J; Kochupillai V
Ann Oncol; 2004 Feb; 15(2):358-9. PubMed ID: 14760137
[No Abstract] [Full Text] [Related]
35. Successful outcome of pregnancy in chronic myeloid leukaemia treated with imatinib.
Heartin E; Walkinshaw S; Clark RE
Leuk Lymphoma; 2004 Jun; 45(6):1307-8. PubMed ID: 15360020
[No Abstract] [Full Text] [Related]
36. Photosensitization in chronic myelogenous leukaemia patients treated with imatinib mesylate.
Rousselot P; Larghero J; Raffoux E; Calvo F; Tulliez M; Giraudier S; Rybojad M
Br J Haematol; 2003 Mar; 120(6):1091-2. PubMed ID: 12648085
[No Abstract] [Full Text] [Related]
37. Improving the management of chronic myeloid leukaemia.
Neylon A; O'Brien S
Hosp Med; 2001 Sep; 62(9):553-5. PubMed ID: 11584615
[TBL] [Abstract][Full Text] [Related]
38. [Evolution of chronic myeloid leukemia on nilotinib after failure of imatinib].
Sawadogo S; Hien FM; Ouédraogo MS; Drabo YJ
Pan Afr Med J; 2014; 18():142. PubMed ID: 25419280
[TBL] [Abstract][Full Text] [Related]
39. Imatinib mesylate, the first molecularly targeted gene suppressor.
Pindolia VK; Zarowitz BJ
Pharmacotherapy; 2002 Oct; 22(10):1249-65. PubMed ID: 12389876
[TBL] [Abstract][Full Text] [Related]
40. Imatinib mesylate noncompliance simulating chronic myeloid leukemia resistance.
Sandoval C; Giamelli J; Jayabose S
J Pediatr Hematol Oncol; 2003 Jun; 25(6):507-8. PubMed ID: 12794534
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
